Today’s most-watched list is a genuine mixed bag — retail attention isn’t limited to gainers, and several of the day’s biggest stories are earnings-driven plunges rather than rallies. Here are the 10 most-watched stocks/symbols today, August 11, 2026, ranked by watchlist activity.
1. Senseonics Holdings (SENS) | Revenue Doubles, Small-Cap Momentum Builds
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $7.79 |
| Today’s Move | +3.32% |
| Volume | 668,293 |
| 52-Week High | $11.58 |
| 52-Week Low | $4.79 |
| Market Cap | $398.67 million |
| Support 1 | $6.50 (recent consolidation) |
| Support 2 | $4.79 (52-week low) |
| Resistance 1 | $8.60 (recent high) |
| Resistance 2 | $11.58 (52-week high) |
| Consensus Price Target | $16.67 |
| Lake Street Target | $14.00 (Buy, reiterated) |
The Catalyst: Senseonics reported Q2 2026 total revenue of $14.48 million, more than double the $6.65 million posted a year earlier, with EPS of 63 cents narrowly topping the 62-cent consensus. Lake Street reiterated its Buy rating with an unchanged $14 price target, citing accelerating growth and pipeline progress even after other firms trimmed targets earlier this year.
Bull Case: Revenue growth of this magnitude for a continuous glucose monitoring (CGM) company signals real commercial traction for its Eversense 365 and Eversense E3 systems, and a consensus target of $16.67 implies more than double the current price if that growth trajectory holds.
Bear Case: Net losses continue widening alongside revenue growth, and Stifel’s target cut to $8 from $9 earlier this year reflects lingering profitability concerns even as the top-line story improves.
Forecast: With shares up 3.32% today and building on a broader multi-week uptrend, watch whether SENS can clear the $8.60 resistance zone to open a path back toward its 52-week high near $11.58.
2. Berkshire Hathaway (BRK.B) | A Rare Down Day for the Market’s Steadiest Name
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $518.71 |
| Today’s Move | -2.02% |
| Volume | 2.56 million |
| 52-Week High | $537.74 |
| 52-Week Low | $464.01 |
| Market Cap | $1.03 trillion |
| Support 1 | $500.00 (psychological level) |
| Support 2 | $464.01 (52-week low) |
| Resistance 1 | $525.00 |
| Resistance 2 | $537.74 (52-week high) |
The Catalyst: Berkshire’s pullback today comes amid a broader session where cyclical and consumer-linked large caps traded weaker alongside rising Treasury yields ahead of Wednesday’s CPI report — Berkshire’s large equity and insurance holdings make it sensitive to both broad market sentiment and rate expectations.
Bull Case: Trading just 3.5% below its 52-week high even after today’s decline, Berkshire’s diversified insurance, energy, and equity holdings continue offering one of the market’s most defensively constructed mega-cap positions heading into a data-heavy week.
Bear Case: A -2.02% single-day move is unusually large for a stock known for low volatility, potentially signaling broader institutional de-risking ahead of Wednesday’s inflation data that could pressure even the market’s most stable names.
Forecast: Watch the $500 psychological support level; a hold there would be consistent with Berkshire’s typical low-volatility trading pattern, while a break below could signal a more significant rotation out of defensive mega-caps.
3. Babcock & Wilcox Enterprises (BW) | Buybacks and a Coal-to-AI Power Pivot
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $9.07 – $9.11 |
| Today’s Move | +2.14% |
| Volume | 16.91 million |
| 52-Week High | $22.03 |
| 52-Week Low | $1.17 |
| Market Cap | $1.32 – $1.36 billion |
| P/E Ratio | -7.79 |
| Support 1 | $8.93 (today’s intraday low) |
| Resistance 1 | $9.79 (today’s intraday high) |
| Resistance 2 | $22.03 (52-week high) |
The Catalyst: Babcock & Wilcox’s board authorized a $50 million share repurchase program following Q2 2026 results, alongside a formal notice of redemption for $61.4 million in 6.50% Senior Notes due August 13. The company also announced a collaboration with TerraSpark on a 1.6 GW coal-fired power project in West Virginia, part of a broader pivot toward AI data center-related power generation contracts that has driven record backlog growth.
Bull Case: A record AI data center-related backlog, sharply reduced debt, and a new $50 million buyback program together signal a company successfully transitioning from legacy power technology toward the AI infrastructure power theme — with the stock still 59% below its 52-week high, there’s substantial room to run if execution continues.
Bear Case: Multiple law firms (Pomerantz, Bernstein Liebhard, Rosen) have announced investor investigations and class actions against the company, and a deeply negative P/E ratio of -7.79 underscores that BW remains unprofitable despite the improving backlog narrative.
Forecast: Watch for the August 13 note redemption to complete without incident, and monitor whether the TerraSpark project reaches a definitive agreement — a signed contract would validate the AI power buildout narrative currently driving the stock’s re-rating.
4. Flowers Foods (FLO) | A Quiet Defensive Name Near Multi-Year Lows
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $7.20 |
| Today’s Move | +0.77% |
| Volume | 2.59 million |
| 52-Week High | $16.85 |
| 52-Week Low | $6.80 |
| Market Cap | $1.51 billion |
| Support 1 | $6.80 (52-week low) |
| Resistance 1 | $8.50 |
| Resistance 2 | $16.85 (52-week high) |
The Catalyst: Flowers Foods, the baker behind Nature’s Own and Dave’s Killer Bread, continues trading near multi-year lows as the packaged food sector broadly grapples with input cost pressure, GLP-1 weight-loss drug-driven changes in consumer carbohydrate consumption, and private-label competition squeezing branded bakery margins.
Bull Case: Trading at less than half its 52-week high, Flowers Foods offers a classic deep-value defensive setup — consumer staples names like this typically see renewed interest during risk-off market rotations, and today’s modest gain suggests some early stabilization near the 52-week low.
Bear Case: The stock’s proximity to its 52-week low of $6.80 reflects genuine structural concerns about bakery category growth in a market increasingly focused on GLP-1-driven dietary shifts, and a modest 0.77% gain does little to reverse the broader downtrend.
Forecast: With shares trading just 40 cents above the 52-week low, this is a critical support test — a decisive break below $6.80 would open further downside, while a bounce here could set up a longer-term value recovery trade.
5. On Holding AG (ONON) | A 22% Earnings Day Collapse
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $30.51 |
| Today’s Move | -21.32% |
| Volume | 34.02 million |
| 52-Week High | $52.20 |
| 52-Week Low | $31.41 (broken intraday) |
| Market Cap | $12.84 billion |
| Q2 2026 EPS | CHF 0.31 (beat CHF 0.29 estimate) |
| Q2 2026 Revenue | CHF 850.3 million (missed CHF 878-881M estimate) |
| Support 1 | $31.41 (former 52-week low, broken today) |
| Support 2 | $30.00 (psychological level) |
| Resistance 1 | $37.00 (recent consolidation zone) |
| Resistance 2 | $46-52.66 (JPMorgan/consensus targets) |
.
The Catalyst: On Holding shares plunged as much as 22% to a roughly two-year low after Q2 net sales of CHF 850.3 million missed analyst estimates, even though EPS beat expectations. Management trimmed its full-year sales growth outlook to the low-20% range from a prior “at least 23%” target. Wholesale revenue growth decelerated sharply to just 4.8% reported, while direct-to-consumer sales — now 45.7% of total revenue — grew a strong 34.3% on a constant-currency basis. A surging Swiss Franc created an 810 basis-point currency headwind on top of the operational slowdown.
Bull Case: JPMorgan maintains an Overweight rating with a $51 target and placed the stock on “Positive Catalyst Watch,” while Evercore ISI raised its target to $46 from $42 even before today’s report — both firms point to DTC strength and intentional wholesale restraint ahead of a major 2027 product wave as reasons the selloff is overdone. The stock is now considered roughly 27% undervalued by some models even before today’s drop factored in fully.
Bear Case: UBS cut its target to $83 from $85, and the broader pattern — slowing Americas growth (13% constant-currency, down from 17% in Q1) plus a full-year guidance cut — suggests genuine demand deceleration rather than pure currency noise, a serious concern for a stock that had commanded a premium growth valuation.
Forecast: With the stock breaking below its prior 52-week low of $31.41 intraday, the next key level to watch is whether it can stabilize above $30 psychological support; a further breakdown would signal the market sees this as a structural growth story reset rather than a one-quarter currency-driven miss.
6. Kratos Defense & Security Solutions (KTOS) | Riding a 6-Day, 31% Winning Streak
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $63.31 |
| Today’s Move | +1.43% |
| Volume | 2.02 million |
| 52-Week High | $134.00 |
| 52-Week Low | $43.09 |
| Market Cap | $11.72 billion |
| 6-Day Performance | +31% |
| Stifel Target | $115 (cut from $134, Buy maintained) |
| Canaccord Target | $135 (raised from $130) |
| Support 1 | $58.00 (6-day rally base) |
| Support 2 | $43.09 (52-week low) |
| Resistance 1 | $70.00 |
| Resistance 2 | $115-135 (analyst target range) |
The Catalyst: Kratos announced a new role in a Missile Defense Agency joint flight experiment today, extending a six-day, 31% winning streak that began with a fresh U.S. Army contract announced August 6. Jefferies and JPMorgan both maintain Buy ratings, while Stifel trimmed its target to $115 from $134 even while keeping its Buy rating intact.
Bull Case: A steady drumbeat of new defense contract wins — Army, Missile Defense Agency — combined with multiple maintained Buy ratings suggests genuine order-flow momentum behind the rally, not just sentiment-driven speculation, and the stock remains well below its 52-week high of $134.
Bear Case: After a 31% six-day run, the stock is due for consolidation or profit-taking, and Stifel’s target cut — even while maintaining its rating — suggests some tempering of near-term expectations after the sharp move.
Forecast: Watch whether KTOS can hold above the $58 zone that marked the start of this rally; continued contract news flow would be needed to justify pushing toward the $70+ level and eventually testing analyst targets in the $115-135 range.
7. The Trade Desk (TTD) | Trading Just Above 5-Year Lows
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $13.35 |
| Today’s Move | -0.34% |
| Volume | 19.83 million |
| 52-Week High | $56.39 |
| 52-Week Low | $12.83 |
| Market Cap | $6.29 billion |
| Support 1 | $12.83 (52-week low) |
| Resistance 1 | $15.00 |
| Resistance 2 | $56.39 (52-week high) |
The Catalyst: The Trade Desk crashed to fresh multi-year lows after a Q2 earnings miss and weak Q3 guidance disappointed investors already nervous about slowing digital advertising growth and mounting competition from Amazon’s demand-side platform. Today’s minor -0.34% move reflects a market that has largely already priced in the disappointment, with shares now trading just 52 cents above the 52-week low.
Bull Case: After an over 75% decline from its 52-week high, TTD trades at a fraction of its former valuation — for investors who believe the company’s core independent ad-tech positioning remains structurally sound, current levels represent a potential deep-value entry point.
Bear Case: A stock hovering just above a fresh 52-week low with no clear positive catalyst signals the market remains deeply skeptical about the company’s competitive position against Amazon and Google’s ad-tech offerings — this is a classic “falling knife” setup until a genuine fundamental inflection point emerges.
Forecast: The $12.83 level is the single most important price to watch; a break below would likely trigger further technical selling, while a sustained hold could finally mark a bottoming process after months of decline.
8. AppLovin Corp (APP) | A Second Straight Week of Analyst Downgrades
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $320.66 |
| Today’s Move | -5.41% |
| Volume | 5.68 million |
| 52-Week High | $745.61 |
| 52-Week Low | $332.19 (broken today) |
| Market Cap | $113.45 billion |
| Q2 2026 Revenue | $1.92 billion (missed ~$1.94-1.95B estimate) |
| Q2 2026 EPS | $3.76 (beat $3.67 estimate) |
| Q3 Guidance | $2.06-2.09B midpoint (below $2.07-2.08B consensus) |
| Wells Fargo Target | $357 (cut from $575, downgraded to Equal Weight) |
| Piper Sandler Target | $385 (cut from $665, downgraded to Neutral) |
| Goldman Sachs Target | $465 (cut from $585, Neutral maintained) |
| Support 1 | $320.00 |
| Support 2 | $300.00 (psychological) |
| Resistance 1 | $343.10 (prior week’s low) |
| Resistance 2 | $465-575 (analyst target range) |
.
The Catalyst: AppLovin broke below its prior 52-week low of $332.19 today, extending a selloff that began August 6 following its first guidance-midpoint miss since going public. Management disclosed that core AXON AI engine upgrades stalled during Q2, with rising inference and R&D costs required to restart algorithmic efficiency gains now threatening near-term cash flow and operating leverage — triggering downgrades from Wells Fargo, Piper Sandler, and continued caution from Goldman Sachs.
Bull Case: Needham’s Bernie McTernan characterized the miss as a temporary “speed bump” rather than a demand issue, pointing to continued double-digit sequential growth in MAX’s publisher-side revenue — with the stock now down 56% from its 52-week high, a resolution of the AXON AI stagnation issue could spark a sharp relief rally.
Bear Case: This marks the first time in 14 straight quarters AppLovin has missed its own guidance band, and with multiple analysts citing “diminished visibility” into the sustainability of its 30% long-term growth trajectory, the market may be repricing the entire growth narrative rather than a single quarter’s execution stumble.
Forecast: With the stock breaking fresh 52-week lows today, watch whether $320 holds as support; further deterioration toward the psychological $300 level would confirm the market views the AXON AI stagnation as a structural, not temporary, problem.
9. AbCellera Biologics (ABCL) | Testing a Fresh 52-Week High
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $9.74 |
| Today’s Move | +4.28% |
| Volume | 14.39 million |
| 52-Week High | $10.01 |
| 52-Week Low | $2.75 |
| Market Cap | $2.86 billion |
| Support 1 | $9.00 |
| Support 2 | $7.00 (post-rally consolidation) |
| Resistance 1 | $10.01 (52-week high) |
The Catalyst: AbCellera continues building on last week’s explosive 38% single-day surge triggered by strong clinical data showing its investigational drug is effective in treating hot flashes, with today’s 4.28% gain pushing shares to within 27 cents of a fresh 52-week high — a remarkable turnaround for a stock that traded as low as $2.75 over the past year.
Bull Case: Sustained follow-through buying days after the initial data catalyst suggests genuine institutional conviction rather than a one-day speculative pop, and a decisive break above the $10.01 52-week high would open uncharted territory for the stock with no recent overhead resistance.
Bear Case: A stock up more than 250% from its 52-week low in a short window carries substantial risk of a sharp reversal on any profit-taking wave, and the underlying hot flash treatment remains in early-stage development with a long road to commercialization still ahead.
Forecast: The $10.01 level is the single price to watch tomorrow — a confirmed breakout above it on strong volume would be a genuinely bullish technical signal, while failure to clear it could trigger a round of profit-taking back toward the $9.00 support zone.
10. AMP Token (AMP) | A Sub-Penny Crypto Asset Holding Steady
Full Data Snapshot:
| Metric | Value |
|---|---|
| Last Price | $0.0004 |
| Today’s Move | +1.40% |
| Market Cap | $35.04 million |
The Catalyst: AMP Token, a collateral token designed to facilitate instant, verifiable transactions across the Flexa payment network, continues trading as a low-priced, small-cap crypto asset with today’s modest gain reflecting broader stability in altcoin markets even as Bitcoin remains range-bound near recent levels.
Bull Case: AMP’s use case as programmable collateral for the Flexa payment network gives it a differentiated utility case relative to purely speculative tokens, and any expansion of Flexa’s merchant payment network could drive renewed demand for AMP as collateral.
Bear Case: At a $35.04 million market cap and a price of four one-hundredths of a cent, AMP remains a deeply speculative, thinly traded asset where liquidity risk is substantial and price moves can be driven by very small absolute dollar flows.
Forecast: With no major company-specific catalyst driving today’s move, AMP’s near-term direction will likely continue tracking broader altcoin sentiment rather than any token-specific development.
Quick-Reference Table: 10 Most-Watched Stocks/Symbols Today
| Rank | Symbol | Company | Last Price | Today’s Move | Market Cap |
|---|---|---|---|---|---|
| 1 | SENS | Senseonics Holdings | $7.79 | +3.32% | $398.67M |
| 2 | BRK.B | Berkshire Hathaway | $518.71 | -2.02% | $1.03T |
| 3 | BW | Babcock & Wilcox | $9.07 | +2.14% | $1.32B |
| 4 | FLO | Flowers Foods | $7.20 | +0.77% | $1.51B |
| 5 | ONON | On Holding AG | $30.51 | -21.32% | $12.84B |
| 6 | KTOS | Kratos Defense | $63.31 | +1.43% | $11.72B |
| 7 | TTD | Trade Desk Inc | $13.35 | -0.34% | $6.29B |
| 8 | APP | AppLovin Corp | $320.66 | -5.41% | $113.45B |
| 9 | ABCL | AbCellera Biologics | $9.74 | +4.28% | $2.86B |
| 10 | AMP | AMP Token | $0.0004 | +1.40% | $35.04M |
Sector Sentiment Snapshot and Forecast
Today’s most-watched list is a study in contrasts: three names (On Holding, AppLovin, and to a lesser extent Berkshire) are being watched precisely because they’re falling sharply, while Kratos, AbCellera, Senseonics, and Babcock & Wilcox represent the opposite — sustained momentum stories drawing continued retail and institutional attention. On Holding’s 22% earnings-day collapse and AppLovin’s break to fresh 52-week lows both stem from the same underlying pattern: strong bottom-line numbers overshadowed by guidance or growth-trajectory concerns, a theme that’s repeated across several high-multiple growth names this earnings season. Meanwhile, Kratos’s defense contract momentum and Babcock & Wilcox’s AI power buildout pivot both reflect the durable “physical economy” and defense infrastructure themes that have persisted throughout 2026. With Wednesday’s CPI report looming, expect continued volatility across this list as investors position ahead of the week’s key macro catalyst.
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and small-cap, low-priced, and crypto assets carry substantially elevated volatility and liquidity risk. Prices, technical levels, and figures cited reflect data available as of August 11, 2026 and are sourced from publicly available market data. Always complete independent due diligence prior to executing equity trades.